We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genzyme Sued As Gene Therapy Pact Falls Apart

Law360 (February 2, 2009, 12:00 AM EST) -- A gene therapy development company with only 13 employees has sued biotechnology giant Genzyme Corp. for allegedly misappropriating its intellectual property and depriving it of at least $5 million in benefits.

In a complaint filed Monday with the U.S. District Court for the Northern District of Florida, Applied Genetic Technologies Corp. asked for a declaratory judgment that Genzyme could not terminate an agreement between the parties right as it was on the verge of achieving milestones that would have triggered obligations to pay AGTC $5 million....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.